Nicox Receives €5 Million Upon Closing of VISUfarma Divestment

July 31, 2020

Sophia Antipolis, France

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that the divestment of its remaining shareholding in VISUfarma, a pan-European ophthalmic specialty pharmaceutical company, has closed as expected and, as per the press release of 10 July 2020,  Nicox has received the funds of €5 million.

Michele Garufi, Chairman and CEO of Nicox, said, “We’re delighted with the conclusion of this transaction and the further strengthening of our balance sheet.

← Back to blog page